Cargando…
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors
In the past decade, induced pluripotent stem cells (iPSCs) technology has significantly progressed in studying malignant solid tumors. This technically feasible reprogramming techniques can reawaken sequestered dormant regions that regulate the fate of differentiated cells. Despite the evolving ther...
Autores principales: | He, Rong, Weng, Zhijie, Liu, Yunkun, Li, Bingzhi, Wang, Wenxuan, Meng, Wanrong, Li, Bo, Li, Longjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661832/ https://www.ncbi.nlm.nih.gov/pubmed/37755647 http://dx.doi.org/10.1007/s12015-023-10633-y |
Ejemplares similares
-
Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
por: Weng, Zhijie, et al.
Publicado: (2021) -
A single‐cell transcriptomic atlas characterizes age‐related changes of murine cranial stem cell niches
por: Li, Bo, et al.
Publicado: (2023) -
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
por: Weng, Zhijie, et al.
Publicado: (2022) -
The application and prospect of CDK4/6 inhibitors in malignant solid tumors
por: Du, Qi, et al.
Publicado: (2020) -
Direct in vivo application of induced pluripotent stem cells is feasible and can be safe
por: Xiang, Meng, et al.
Publicado: (2019)